DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20184332

Study of prescription pattern of antiglaucoma drugs used in treatment of primary open angle glaucoma in ophthalmology outpatient department of a tertiary care hospital

Manjari Advani, Trupti Jadhao

Abstract


Background: In view of the high prevalence rates and the fact that medication is the primary line of treatment in POAG, an understanding of prescribing patterns can provide an insight into rational use of antiglaucoma drugs.

Methods: This prospective, cross-sectional study was conducted in the glaucoma clinic of a tertiary care teaching hospital over a period of 12 months. Data from prescriptions of patients with POAG was recorded to study the prescribing pattern of antiglaucoma medications, completeness of the prescription and analysis of the prescriber’s influence.

Results: Total of 103 prescriptions were included in which all the 141 anti-glaucoma drugs were prescribed as eye drops. Average number of drugs prescribed in present study was 1.36.   β blockers, particularly Timolol (58%) was the most frequently prescribed drug. Timolol with dorzolamide (15%) was the only prescribed fixed dose combination. Prostaglandin analogues (5%) were least commonly prescribed. 53% drugs were prescribed by generic names and 43% were prescribed from hospital formulary. Instructions regarding the route and frequency of drug administration with duration of treatment were present in all prescriptions; however, instructions regarding method of instillation of eye drops were missing. Authors observed prescriber’s influence in present study.

Conclusions: Overall prescribing pattern in our set up is satisfactory. There is a need to sensitize the prescribers regarding the importance of writing method of instillation in prescription as this could improve efficacy reduce side effects, prevent drug wastage and reduce cost. To encourage the physicians for rational prescribing such type of studies should be done more often for periodic auditing of prescriptions.


Keywords


Drug utilization study, Dorzolamide, Glaucoma, Timolol, Prescription

Full Text:

PDF

References


Tanuj D, Ichhpujani PSR. Glaucoma - leading cause of Blindness. Natl Program Control Blind India Newsl. 2013;Jan-Mar(March):1-8.

Klein BE, Klein R, Sponsel WE, Franke T, Cantor LB, Martone J, et al. Prevalence of glaucoma: the Beaver Dam eye study. Ophthalmol. 1992 Oct 1;99(10):1499-504.

WHO. International WG for drug statistics methodology. Introduction to drug utilization research. Solutions. 2003:1-48.

Singh K, Shrivastava A. Medical management of glaucoma: principles and practice. Indian J Ophthalmol. 2011 Jan;59(Suppl1):S88.

Parikh RS, Parikh SR, Navin S, Arun E, Thomas R. Practical approach to medical management of glaucoma. Indian J Ophthalmol. 2008 May;56(3):223.

Kulkarni SV, Damji KF, Buys YM. Medical management of primary open-angle glaucoma: Best practices associated with enhanced patient compliance and persistency. Patient Preference Adherence. 2008;2:303.

Kumar R, Suman P, Ray Mohanty, Deshmukh YA. Drug Utilization studies in Glaucoma patients at MGM medical College and Hospital. Int J sci Res. 2013;433(7):433-5.

Mahajan A, Gupta AK, Singh G. A study of prescribing pattern of medical therapy in glaucoma patients. World J Pharm Res. 2016;5(6):1030-43.

Mahajan HM, Honrao R, Borkar AS, Badwaik RT, Chopade SS, Surwase P. A drug utilization study in glaucoma patients in a tertiary care hospital of central India. J Cont Med A Dent. 2015;3(2):44-7.

Deepalatha C, Pratyusha L. To study the drug use pattern in primary open-angle glaucoma in a tertiary care teaching hospital. Asian J Pharm Clin Res. 2017;10(2):198-200.

Sharma R, Khajuria R, Sharma P, Sadhotra P, Kapoor B, Kohli K, et al. Glaucoma therapy: prescribing pattern and cost analysis. JK Sci. 2004;6(2):88-92.

Yadav AK, Patel V. Drug use in primary open angle glaucoma: a prospective study at a tertiary care teaching hospital. Indian J Pharmacol. 2013 Mar;45(2):117.

Carroll SC, Gaskin BJ, Goldberg I, Danesh‐Meyer HV. Glaucoma prescribing trends in Australia and New Zealand. Clin Exp Ophthalmol. 2006 Apr;34(3):213-8.

Gupta N, Tin A, Congdon NG, Dada T, Lerner F, Olawoye S, et al. ICO Guidelines for Glaucoma Eye Care. Int Counc Ophthalmol. 2015. Available at: http://www.icoph.org/downloads/ICOGlaucomaGuidelines.pdf.

Ahmed QS, Sayedda K, Agarwal A, Ansari NA. Drug utilization study of antiglaucoma drugs in a tertiary care teaching hospital, Bareilly. World J Pharmaceut Res. 2013;3(2):2420-8.

Andrade C, Rao TS. Prescription writing: generic or brand?. Indian J Psychiatry. 2017 Apr;59(2):133.

Gagne JJ, Polinski JM, Jiang W, Dutcher SK, Xie J, Lii J, et al. Outcomes associated with generic drugs approved using product-specific determinations of therapeutic equivalence. Drugs. 2017 Mar 1;77(4):427-33.

Ministry of health and family welfare. Nlem India 2015. Available at: http://cdsco.nic.in/WriteReadData/NLEM-2015/NLEM, 2015.pdf.

Biswas NR, Jindal S, Siddiquei MM, Maini R. Patterns of prescription and drug use in ophthalmology in a tertiary hospital in Delhi. Br J Clin Pharmacol. 2001 Mar;51(3):267-9.

Flach AJ. The importance of eyelid closure and nasolacrimal occlusion following the ocular instillation of topical glaucoma medications, and the need for the universal inclusion of one of these techniques in all patient treatments and clinical studies. Transactions Am Ophthalmol Soc. 2008 Dec;106:138.